Related Experiment Video
Updated: Aug 10, 2026

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
Increased S-100 protein-immunoreactivity of Kupffer cells is associated with lymphohematological malignancy
1Laboratory for Cell Biology and Histology, Faculty of Medicine and Pharmacy, Free University of Brussels, Belgium.
Insights
Increased S-100 protein expression in Kupffer cells of the liver was significantly linked to lymphohematologic malignancies. This suggests a potential tumor-induced response in these immune cells.
Area of Science:
- Hepatology
- Immunology
- Oncology
Background:
- S-100 protein expression is well-documented in normal tissues.
- Limited data exists on S-100 protein expression in pathological conditions, particularly in liver diseases.
- Kupffer cells, the resident macrophages of the liver, play a crucial role in hepatic immunity and disease.
Purpose of the Study:
- To investigate the expression of S-100 protein in diseased human liver tissue.
- To specifically examine S-100 protein expression in Kupffer cells.
- To determine any association between S-100 protein expression in Kupffer cells and specific disease states.
Main Methods:
- Examination of 100 autopsy liver samples from patients with diverse diseases.
- Immunohistochemical analysis to detect S-100 protein expression.
- Statistical analysis to assess the association between S-100 positive Kupffer cells and lymphohematologic malignancy.
Main Results:
- Increased S-100 immunoreactivity was observed in Kupffer cells in six cases.
- Four of these cases with elevated S-100 expression were associated with lymphohematologic malignancies.
- A significant association (P < 0.01) was found between increased S-100 positive Kupffer cells and lymphohematologic malignancy (25% vs 2.4%).
- Some S-100 positive Kupffer cells also expressed the S-100 beta-subunit, not typically found in these cells.
Conclusions:
- Increased S-100 protein expression in Kupffer cells is significantly associated with lymphohematologic malignancy.
- The findings suggest a potential tumor-induced modulation of S-100 protein expression in Kupffer cells.
- Further research is needed to elucidate the specific factors and mechanisms involved in this phenomenon.
Abstract:
The distribution of S-100 protein in normal tissue has been studied extensively. However, little is known about its expression in pathologic states. The aim of the present study was to investigate the expression of S-100 protein in diseased human liver, especially in Kupffer cells. One hundred cases of autopsy livers originating from patients with various diseases were examined. Increased S-100-immunoreactivity of Kupffer cells was observed in six cases. Of the six cases, four were derived from a lymphohematologic malignancy, such as B cell lymphoma, B cell lymphoblastic leukemia, multiple myeloma and chronic myelogenous leukemia with lymphoblastic crisis. Lymphohematologic malignancy accounted for 16 out of the 100 cases examined. Thus, increased S-100-positive Kupffer cells was significantly associated with lymphohematologic malignancy (P < 0.01); 25% (4/16) in cases with lymphohematologic malignancy versus 2.4% (2/84) in the remaining cases. Moreover, some of these S-100-positive Kupffer cells were positive for S-100 beta-subunit, which is not normally expressed by Kupffer cells. Although the reason for this increased S-100-immunoreactivity is speculative, the authors' hypothesis is that tumor cells may produce some factor(s) that induce the expression of S-100 protein in Kupffer cells.
More Related Videos
11:00Multiplex Cytokine Profiling of Stimulated Mouse Splenocytes Using a Cytometric Bead-based Immunoassay Platform
Published on: November 9, 2017
07:32Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software
Published on: April 12, 2024